Clinical research is the cornerstone of progress in oncology. Every new therapy, diagnostic tool, and supportive care intervention relies on well-designed clinical trials to generate high-quality evidence. Yet, the success of a clinical trial depends on much more than the investigational treatment itself. Patient identification, enrollment, education, symptom management, adherence, retention, and accurate data collection all contribute to whether a study ultimately succeeds.
Advanced Practice Providers (APPs) are uniquely positioned to influence each of these elements.
Clinical Research Is an Extension of Advanced Practice Nursing
The role of the APP in clinical research is not fundamentally different from the role performed in everyday clinical practice. Rather, clinical research provides another environment in which the core competencies of advanced practice nursing are applied.
Hamric and Hanson's Advanced Practice Nursing framework describes advanced practice through competencies including direct clinical practice, expert coaching and guidance, consultation, research, leadership, collaboration, and ethical decision-making. These competencies translate naturally into the clinical research setting.
Whether caring for patients receiving standard therapy or participating in a clinical trial, APPs remain focused on delivering evidence-based, patient-centered care while coordinating multidisciplinary teams and supporting informed decision-making.
Improving Patient Access to Clinical Trials
One of the earliest opportunities for APP involvement occurs before a patient is enrolled in a study.
Because APPs frequently conduct new patient visits, longitudinal follow-up, and treatment planning, they are well positioned to identify potentially eligible patients, introduce clinical trial opportunities, and facilitate timely referrals to research teams. Their established therapeutic relationships also allow them to address misconceptions, answer questions, and support shared decision-making throughout the enrollment process.
Expanding patient access to clinical trials remains one of the greatest opportunities for improving cancer research.
Supporting Patients Throughout the Clinical Trial Continuum
The APP role extends far beyond enrollment.
Throughout study participation, APPs contribute to:
- Patient education regarding investigational therapies and protocol requirements.
- Symptom assessment and toxicity management.
- Adverse event recognition and grading.
- Support for treatment adherence.
- Coordination among investigators, research coordinators, nurses, pharmacists, and other multidisciplinary team members.
- Longitudinal follow-up and survivorship care.
These responsibilities not only improve patient experiences but also strengthen protocol adherence and study integrity.
Symptom Management Is a Research Intervention
Effective symptom management is often viewed primarily as a clinical responsibility. However, within clinical research, it also becomes a critical research intervention.
Uncontrolled toxicities can lead to emergency department visits, hospitalizations, dose reductions, treatment delays, protocol deviations, or early withdrawal from clinical trials. These events affect both individual patient outcomes and the quality of study data.
By proactively identifying and managing adverse events, APPs help patients remain safely on study while preserving protocol compliance and supporting reliable trial outcomes.
Evidence Supporting APP Integration
Growing evidence demonstrates that integrating APPs into oncology research programs improves both patient care and research performance.
Programs within the National Cancer Institute Community Oncology Research Program (NCORP) have reported substantial improvements in clinical trial accrual following intentional APP integration. Similarly, implementation within early-phase oncology programs has been associated with increased enrollment, expanded patient access, and greater research capacity.
Recognizing these findings, a recent multi-society position paper published in the Journal of the National Cancer Institute advocates for meaningful integration of oncology APPs into clinical cancer research as a standard component of high-quality oncology care.
Overcoming Barriers
Despite their demonstrated value, APP participation in clinical research remains inconsistent across institutions.
Common barriers include:
- Limited protected research time.
- High clinical workloads.
- Insufficient research education and mentorship.
- Restrictive institutional policies.
- Limited opportunities for research leadership.
Importantly, these barriers are largely organizational rather than professional. Healthcare leaders play a critical role in creating environments where APPs can fully contribute to clinical research through dedicated infrastructure, mentorship, education, and institutional support.
Looking Forward
As oncology care becomes increasingly complex, clinical research requires multidisciplinary teams capable of delivering both scientific rigor and patient-centered care.
APPs bridge clinical practice and research by combining advanced clinical expertise with longitudinal patient relationships, interdisciplinary collaboration, and operational knowledge. Their contributions extend across the entire clinical trial continuum—from identifying eligible participants and supporting enrollment to managing toxicities, improving adherence, and promoting long-term follow-up.
Integrating APPs into clinical research is not simply an opportunity for professional role expansion; it is an opportunity to strengthen clinical trial performance, improve patient outcomes, and accelerate the generation of high-quality evidence that advances cancer care.
References
Braun-Inglis, C. M., Dressler, E. V., Myers, J. S., Benson, A. B., III, Flannery, M., Good, M., Denicoff, A., Berenberg, J. L., DeTroye, A. T., O'Brien, B., Kottschade, L., Omatsu, D. A., Kittel, C. A., Nightingale, C. L., Foust, M., & Lesser, G. J. (2024). Defining the role of the advanced practice provider within the National Cancer Institute Community Oncology Research Program. JCO Oncology Practice, 20(2), 239–246. https://doi.org/10.1200/OP.23.00501
Braun-Inglis, C., Myers, J. S., O'Brien, B., et al. (2026). Integrating oncology advanced practice providers and clinical pharmacists into clinical cancer research. Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djag125
Falcone, J., et al. (2025). Leveraging advanced practice providers in a clinical research program to provide trial prescreening and counseling increases clinic volume and trial accruals. Journal of Clinical Oncology, 43(Suppl. 16), Abstract e13529.
Harbman, P., Bryant-Lukosius, D., Martin-Misener, R., et al. (2017). Partners in research: Building academic-practice partnerships to educate and mentor advanced practice nurses. Journal of Evaluation in Clinical Practice, 23(2), 382–390. https://doi.org/10.1111/jep.12630
Huang, X., et al. (2022). The effectiveness of nurse-led interventions for cancer symptom management 2000–2018: A systematic review and meta-analysis. Health Science Reports, 5, e100052. https://doi.org/10.1016/j.hsr.2022.100052
Tracy, M. F., O'Grady, E. T., & Phillips, S. J. (Eds.). (2023). Hamric & Hanson's advanced practice nursing: An integrative approach (7th ed.). Elsevier.
*AI Disclosure: ChatGPT (OpenAI) was used to assist with language review and editorial refinement. All scientific content, interpretations, and conclusions were developed, reviewed, and approved by the author, who assumes full responsibility for the final manuscript.